background
type
ii
integr
membran
protein
express
extracellular
envelop
form
vaccinia
viru
vacv
passiv
transfer
monoclon
antibodi
vaccin
subunit
vaccin
confer
protect
lethal
poxviru
challeng
anim
model
homolog
highli
conserv
among
member
orthopoxviru
genu
potenti
candid
inclus
vaccin
assay
target
extracellular
envelop
viru
activ
one
monoclon
antibodi
direct
vacv
shown
target
conformationdepend
epitop
interestingli
recogn
vacv
well
correspond
variola
homolog
bind
monkeypox
homolog
studi
util
random
phage
display
librari
investig
epitop
recogn
critic
facilit
celltocel
spread
vaccinia
viru
result
screen
linear
conform
random
phage
librari
found
phage
bind
display
consensu
motif
ceplc
disulfid
bond
form
two
cystein
residu
requir
bind
although
phage
motif
contain
linear
sequenc
homolog
vacv
structur
model
analysi
suggest
residu
import
form
minim
epitop
core
panel
point
mutant
express
ectodomain
protein
gener
analyz
either
bind
assay
elisa
immunoprecipit
function
assess
block
mediat
comet
inhibit
cell
cultur
conclus
result
confirm
compon
bind
epitop
identifi
essenti
residu
defin
minimum
conform
structur
well
conform
arrang
short
peptid
sequenc
recogn
result
introduc
possibl
design
small
molecul
mimet
may
interfer
function
vivo
inform
also
use
design
improv
assay
evalu
potenc
monoclon
polyclon
product
target
ev
dissemin
despit
erad
natur
occur
smallpox
licens
smallpox
vaccin
still
administ
militari
personnel
first
respond
due
threat
bioterror
well
individu
potenti
exposur
monkeypox
februari
center
diseas
control
prevent
cdc
dispos
last
million
dose
dryvax
licens
first
gener
smallpox
vaccin
grown
skin
calv
new
vaccin
licens
food
drug
administr
replac
replicationcompet
vaccinia
viru
clone
deriv
dryvax
manufactur
larg
scale
mammalian
cell
cultur
efficaci
determin
number
anim
model
found
noninferior
dryvax
elicit
immunolog
respons
howev
similar
safeti
profil
compar
dryvax
introduc
level
risk
small
subset
individu
complic
may
sever
lifethreaten
sever
advers
event
follow
vaccin
may
includ
eczema
vaccinatum
ev
patient
atop
dermat
certain
skin
condit
progress
vaccinia
pv
immunocompromis
patient
vaccinia
immun
globulin
intraven
human
vigiv
polyclon
antibodi
prepar
manufactur
plasma
vacciniaimmun
donor
licens
therapi
smallpox
vaccin
complic
placebocontrol
clinic
trial
perform
current
avail
vigiv
product
use
similar
product
histor
decreas
mortal
pv
ev
review
sever
case
high
repeat
dose
vigiv
use
context
widespread
vaccin
vigiv
suppli
could
limit
enhanc
potenc
licens
vigiv
challeng
part
viru
neutral
assay
screen
donor
plasma
labori
requir
live
viru
subject
variabl
typic
encount
biolog
assay
bind
assay
quantit
antibodi
level
problemat
absenc
specif
epitop
bind
inform
context
polyclon
prepar
may
contain
mixtur
neutral
nonneutr
antibodi
therefor
typic
support
use
plaqu
reduct
neutral
assay
sinc
immunogen
critic
consider
vaccin
develop
structur
understand
critic
viral
protein
epitop
would
aid
develop
feasibl
assay
capabl
measur
import
antibodi
specif
donor
plasma
vigiv
poxviru
infecti
life
cycl
approxim
intracellular
matur
virion
imv
wrap
addit
membran
exocytos
extracellular
envelop
viru
eev
review
imv
may
mediat
hosttohost
transmiss
eev
thought
uniqu
respons
rapid
spread
viru
vivo
present
import
antibodi
target
antibodymedi
inhibit
eev
releas
infect
cell
blockad
eev
entri
demonstr
passiv
immun
effect
polyclon
antibodi
prepar
contain
higher
eev
antibodi
titer
antieev
monoclon
provid
protect
mous
vaccinia
intranas
challeng
model
vaccin
eev
protein
also
elicit
protect
immun
respons
unfortun
immun
individu
antieev
titer
vari
consider
may
declin
time
postvaccin
antieev
antibodi
level
also
variabl
among
differ
vig
product
kennedi
r
fisher
unpublish
data
suggest
potenc
gain
might
realiz
select
plasma
donor
robust
respons
eev
neutral
surfac
determin
howev
identif
character
eev
neutral
determin
still
incomplet
assay
measur
eev
neutral
activ
subject
high
degre
variabl
eev
envelop
contain
sever
viral
protein
includ
among
protein
known
neutral
viral
spread
inhibit
target
associ
eev
membran
andor
infect
cell
protein
appear
regul
eev
egress
cell
interact
antagon
superinfect
neighbor
cell
promot
rapid
longdist
dissemin
antibodi
direct
block
comet
format
vitro
protect
poxviru
challeng
vivo
passiv
transfer
model
initi
character
monoclon
antibodi
could
provid
partial
protect
vivo
intranas
vacvwr
challeng
mous
model
well
block
ev
spread
cell
cultur
although
disconnect
protect
efficaci
antibodi
affin
demonstr
antibodi
rais
evalu
part
effort
identifi
epitop
might
crossprotect
multipl
pathogen
poxvirus
analysi
show
sensit
epitop
vaccinia
present
monkeypox
ortholog
interpret
bind
epitop
conform
natur
bind
monkeypox
protein
could
restor
singleresidu
exchang
posit
chang
monkeypox
sequenc
vaccinia
sequenc
base
inform
residu
implic
core
residu
form
epitop
import
region
reinforc
crystallograph
data
fragment
ectodomain
residu
dimer
rich
structur
model
vaccinia
structur
similar
ctype
lectin
propos
describ
structur
featur
stabil
intramolecular
disulfid
bond
residu
map
surfaceexpos
edg
propos
monom
structur
well
remov
dimer
propos
ligandbind
interfac
provid
addit
character
epitop
involv
cell
cell
spread
vaccinia
consid
whether
addit
residu
might
influenc
bind
context
vaccinia
protein
studi
screen
random
peptid
phage
display
librari
find
peptid
specif
bound
conform
constrain
consensu
motif
seven
residu
analyz
avail
sequenc
structur
inform
gener
epitop
model
test
confirm
alanin
site
direct
mutagenesi
approach
result
demonstr
neg
charg
requir
bind
help
establish
minimum
epitop
core
bind
intact
vaccinia
protein
data
also
confirm
residu
contribut
epitop
format
agreement
previou
observ
studi
show
unbias
map
strategi
util
random
peptid
display
technolog
effect
map
linear
conform
epitop
involv
facilit
cell
cell
spread
vaccinia
work
also
expand
understand
import
orthopoxviru
epitop
may
exploit
improv
inform
therapi
vaccinia
potenti
smallpox
consid
align
sequenc
poxviru
homolog
figur
note
subtl
pattern
altern
highlycharg
residu
hydrophob
stretch
strike
heterogen
charg
residu
propos
region
epitop
nonconval
interact
among
charg
hydrophob
residu
influenc
region
conform
context
epitop
exampl
present
epitop
monkeypox
versu
vaccinia
backbon
might
yield
differ
epitop
map
inform
basi
decid
pursu
addit
character
epitop
obtain
unbias
inform
conform
distinct
epitop
interact
disulfideconstrain
heptapeptid
librari
screen
approach
use
approach
random
peptid
segment
flank
pair
cystein
oxid
phage
assembl
present
peptid
taut
loop
nterminu
minor
phage
coat
protein
piii
ten
bind
peptid
isol
conform
librari
screen
none
contain
vaccinia
viru
sequenc
figur
two
consensu
motif
identifi
cxxi
f
nepl
f
c
cxxxwpf
h
ec
biotinyl
peptid
mimic
subsequ
construct
verifi
bind
solidphas
assay
figur
strong
interact
one
peptid
contain
cxxi
f
nepl
f
c
motif
confirm
elisa
base
assay
figur
observ
nethylmaleimid
treatment
reduc
peptid
block
bind
figur
suggest
intact
disulfid
bond
import
epitop
conform
second
pass
librari
screen
undertaken
determin
addit
consensu
motif
might
obtain
second
screen
util
phage
librari
linear
dodecapeptid
present
nterminu
phage
coat
protein
piii
two
bind
peptid
obtain
screen
linear
peptid
librari
neither
contain
viral
sequenc
contain
consensu
ceplc
motif
figur
comparison
peptid
sequenc
obtain
librari
screen
suggest
conform
constrain
ceplc
sequenc
like
function
ident
minim
core
epitop
celpc
sequenc
present
vaccinia
reason
conform
constrain
celpc
motif
might
identifi
fold
protein
molecular
model
short
consensu
celpc
peptid
construct
figur
aid
identifi
potenti
bind
region
intact
molecul
molecular
coordin
two
loop
pdbid
sequenc
c
dplc
without
pdbid
c
gglc
disulphid
bond
extract
although
structur
loop
presenc
absenc
disulphid
bond
prescrib
differ
topolog
sequenc
better
visual
differ
mutat
cgglc
sequenc
silico
phage
consensu
sequenc
ceplc
use
pymol
subsequ
undertook
energi
minim
model
step
vacuum
use
charmm
field
result
model
show
disulfid
bond
ceplc
peptid
featur
angstrom
distanc
charg
glutam
side
chain
hydrophob
leucin
residu
wherea
reduc
loop
similar
distanc
aspartateleucin
angstrom
model
accur
two
outcom
possibl
first
reduc
disulphid
bond
would
reduc
bind
phage
peptid
antibodi
virtu
alter
conform
loop
second
importantli
matur
molecul
must
contain
surfac
residu
similar
e
l
similar
rel
posit
consensu
phage
peptid
probe
publish
structur
surfaceexpos
region
distanc
charg
hydrophob
residu
similar
ceplc
peptid
yield
possibl
match
residu
figur
separ
angstrom
structur
model
protein
howev
given
result
heptapeptid
phage
display
could
rule
altern
possibl
complex
interact
among
might
influenc
shape
epitop
long
rang
hydrogen
bond
interact
figur
alanin
scan
techniqu
use
determin
either
hypothes
regard
epitop
structur
might
correct
accomplish
ectodomain
wild
type
residu
express
e
coli
histag
recombin
protein
isol
inclus
bodi
refold
affin
purif
column
confirm
process
protein
refold
nativ
solubl
protein
also
gener
e
coli
cytosol
fraction
compar
purpos
bind
found
compar
elisa
immunoprecipit
figur
b
well
anoth
mab
elisa
sinc
protein
recoveri
yield
much
higher
protein
isol
inclus
bodi
chose
util
refold
recombin
protein
character
use
site
direct
mutagenesi
prepar
seri
variant
alanin
residu
individu
substitut
addit
seri
doubl
alanin
substitut
variant
quadrupl
alanin
substitut
variant
construct
success
express
e
coli
similar
effici
puriti
compar
e
coli
express
wild
type
recombin
supplement
figur
bind
disrupt
mutat
posit
suggest
residu
critic
epitop
contrast
alanin
substitut
residu
prevent
interact
confirm
epitop
use
vitro
function
test
inhibit
eev
spread
function
evalu
vitro
use
establish
method
eev
releas
infect
cell
rapidli
form
satellit
plaqu
commonli
refer
comet
assay
addit
supernat
follow
adsorpt
viru
target
cell
block
develop
satellit
plaqu
dosedepend
manner
comet
block
figur
demonstr
function
relev
assay
test
abil
phage
recombin
protein
prepar
interfer
comet
neutral
capac
phage
express
celpc
consensu
motif
figur
includ
comet
assay
along
satellit
plaqu
restor
demonstr
activ
abolish
convers
variant
protein
contain
mutat
ad
comet
assay
along
effect
cometneutr
activ
confirm
loss
function
epitop
mutant
protein
figur
addit
variant
protein
effect
activ
comet
assay
data
shown
interestingli
contain
mutat
retain
abil
interact
figur
use
random
peptid
librari
screen
evalu
comet
inhibit
epitop
recogn
monoclon
antibodi
phage
technolog
offer
opportun
explor
interact
determin
protein
without
preexist
assumpt
context
interact
case
conform
constrain
peptid
sequenc
identifi
librari
screen
success
match
put
surfaceexpos
region
vaccinia
previous
implic
bind
howev
analysi
implic
new
upstream
residu
bind
residu
complet
conserv
among
strandloophelix
region
protein
similar
phage
display
peptid
ceplc
see
text
shown
leucin
aspart
side
chain
depict
stick
represent
distanc
display
c
altern
conform
epitop
also
consist
phage
display
data
longrang
interact
residu
could
involv
mutat
analysi
support
hypothesi
polar
group
shown
broken
line
member
orthopoxviru
genu
role
bind
consid
previou
studi
block
vivo
dissemin
vaccinia
viru
import
approach
control
complic
vaccin
risk
individu
poxviru
spread
within
host
acceler
doubleenvelop
eev
propel
actin
tail
releas
prior
target
cell
lysi
one
protein
present
eev
surfac
delet
gene
vaccinia
viru
reduc
diseas
experiment
infect
model
due
ineffici
celltocel
spread
also
shown
interact
cytoplasm
transmembran
region
eev
protein
togeth
may
enhanc
longrang
figur
bind
assay
evalu
protein
contain
alanin
residu
specifi
locat
protein
use
elisa
format
assay
captur
b
test
abil
bind
immunoprecipit
assay
figur
bind
phage
interfer
abil
block
eevmedi
viru
spread
well
label
mab
receiv
hour
post
infect
either
control
phage
phage
express
consensu
sequenc
pfuml
pfuml
pfuml
monolay
fix
stain
hour
post
infect
viral
dissemin
limit
superinfect
nearbi
cell
vaccineinduc
passiv
transfer
antibodi
mediat
protect
lethal
orthopoxviru
diseas
anim
model
critic
compon
vaccinia
virul
neutral
strategi
target
protein
may
particularli
effect
thu
requir
appropri
potenc
assay
antieev
antibodi
respons
without
except
import
prophylaxi
treatment
poxvirus
anim
model
howev
serolog
assess
antieev
antibodi
human
smallpox
vaccin
studi
compon
passiv
antibodi
therapi
limit
part
due
use
wellestablish
prnt
assay
measur
antiimv
antieev
activ
measur
eev
activ
proven
challeng
due
fragil
natur
viral
envelop
infecti
natur
eev
imv
form
viru
comet
inhibit
assay
eev
antibodi
use
research
studi
difficult
valid
provid
robust
quantitit
result
import
measur
antieev
antibodi
underscor
observ
antibodi
level
variabl
polyclon
vigiv
prepar
use
research
test
fisher
kennedi
unpublish
bind
assay
elisa
offer
sever
advantag
term
reproduc
speed
robust
howev
truli
predict
potenc
assay
specif
known
neutral
epitop
epitop
current
studi
provid
thorough
character
conform
comet
inhibit
epitop
link
epitop
viral
spread
assay
peptid
mimic
reflect
bind
epitop
test
robust
solid
phase
assay
format
develop
optim
assay
evalu
vigiv
product
current
underway
addit
method
could
use
effici
screen
plasma
vaccin
donor
inclus
plasma
pool
use
manufactur
vigiv
convalesc
plasma
intend
therapi
event
smallpox
outbreak
comprehens
optim
antieev
assay
includ
one
eev
epitop
assess
unless
presenc
antibodi
shown
gener
marker
robust
antieev
respons
limit
broader
approach
lack
detail
structur
inform
import
target
eev
protein
absenc
data
valid
peptid
identifi
random
display
approach
challeng
anoth
consider
accur
reflect
provid
correl
effector
mechan
complement
fc
receptor
involv
futur
studi
includ
structur
analysi
key
vaccinianeutr
target
support
random
peptid
librari
screen
effort
well
evalu
neutral
epitopeeffector
mechan
interact
risk
seriou
side
effect
current
live
attenu
vaccinia
viru
vaccin
provid
impetu
renew
effort
develop
safer
effect
altern
far
approach
develop
safe
smallpox
vaccin
rang
studi
highli
attenu
live
vaccinia
virus
use
alphaviru
replicon
vector
express
vaccinia
gene
subunit
vaccin
deliv
either
dna
plasmid
purifi
protein
altern
approach
vaccin
design
use
molecul
mimic
immunogen
element
interest
exampl
peptid
mimic
coupl
carrier
protein
present
polym
develop
cancer
antiallerg
contracept
vaccin
interestingli
peptid
mimic
need
similar
linear
sequenc
antigen
reli
use
conform
depend
epitop
stimul
antibodi
crossreact
target
antigen
result
confirm
compon
bind
epitop
identifi
essenti
residu
defin
minimum
conform
structur
well
conform
arrang
short
peptid
sequenc
recogn
result
introduc
possibl
design
small
molecul
mimic
may
interfer
function
vivo
current
studi
demonstr
interdisciplinari
approach
integr
conform
peptid
display
structur
map
biolog
relev
assay
provid
complet
character
import
vaccinia
epitop
find
suggest
addit
option
vaccin
subunit
develop
possibl
use
streamlin
assay
assess
antieev
vaccin
respons
provid
path
toward
improv
potenc
evalu
passiv
immun
therapi
human
orthopoxviru
diseas
ihdj
strain
vaccinia
viru
obtain
laboratori
bernard
moss
niaid
passag
vero
cell
atcc
vero
cell
maintain
cdmem
dubelco
minim
essenti
media
contain
fetal
bovin
serum
mgml
dglucos
sodium
pyruv
nonessenti
amino
acid
uml
penicillinstreptomycin
amphotericin
infect
low
moi
hour
incub
monitor
cytopath
effect
daili
day
postinfect
cell
cell
cultur
supernat
remov
centrifug
tube
spun
minut
g
eppendorf
model
centrifug
equip
swing
bucket
rotor
result
cell
pellet
resuspend
cold
cdmem
process
chill
dounc
homogen
clarifi
centrifug
g
minut
supernat
disrupt
use
cup
horn
sonic
cycl
compos
second
power
duti
cycl
follow
second
ice
aliquot
remov
check
steril
viral
titer
remaind
aliquot
frozen
hybridoma
grown
bd
cell
monoclon
antibodi
medium
fisher
hybridoma
supernat
appli
protein
affin
column
ge
healthcar
extens
wash
pb
bound
antibodi
elut
glycin
ph
immedi
neutral
trishcl
ph
select
peptid
random
peptid
phage
display
librari
new
england
biolab
beverli
describ
previous
briefli
phage
incub
monoclon
antibodi
protein
g
mixtur
min
room
temperatur
eight
wash
trishcl
buffer
ph
contain
nacl
tween
phage
elut
complex
hcl
min
room
temperatur
neutral
trishcl
ph
elut
phage
amplifi
host
strain
precipit
nacl
three
addit
round
select
amplifi
phage
dna
wellsepar
plaqu
sequenc
correspond
peptid
sequenc
deduc
dna
sequenc
molecular
coordin
protein
pdb
use
structur
analysi
model
obtain
protein
data
bank
visual
analyz
use
pymol
pymol
molecular
graphic
system
version
llc
model
structur
consensu
posit
phage
display
peptid
structur
databas
queri
use
blast
short
sequenc
contain
two
cystein
separ
three
amino
acid
cxxxc
structur
return
search
examin
presenc
absenc
disulphid
bond
local
conform
differ
sequenc
extract
databas
alter
sequenc
phage
display
peptid
energi
minim
use
charmm
compar
possibl
locu
epitop
briefli
dna
sequenc
encod
residu
wild
type
amplifi
pcr
vaccinia
viru
western
reserv
strain
facilit
protein
purif
refold
tag
peptid
linker
introduc
n
termin
region
construct
final
pcr
product
clone
bd
bioscienc
util
construct
templat
plasmid
encod
contain
desir
mutat
construct
use
kit
site
direct
mutagenesi
new
england
biolab
accord
manufactur
instruct
use
primer
describ
tabl
accuraci
result
construct
verifi
dna
sequenc
e
coli
strain
transform
result
plasmid
cultur
valu
approxim
induc
mm
iptg
hour
bacteria
collect
centrifug
minut
g
result
cell
pellet
wash
pb
resuspend
mgml
lysozym
pb
incub
room
temperatur
hour
subject
sonic
ice
three
cycl
minut
altern
bacteria
resuspend
mm
tri
mm
nacl
mm
edta
ph
lyse
french
press
inclus
bodi
collect
centrifug
g
minut
wash
triton
solubil
overnight
guanidin
mm
tri
mm
dtt
ph
incub
ninta
agaros
bead
hour
room
temperatur
bead
load
onto
econopac
column
biorad
wash
column
volum
guanidin
protein
fold
facilit
wash
decreas
concentr
guanidin
final
wash
pb
refold
protein
elut
column
mm
inidazol
pb
ph
dialyz
pb
extens
buffer
chang
protein
solut
clarifi
centrifug
g
result
supernat
snapfrozen
liquid
nitrogen
store
express
purifi
solubl
recombin
protein
ecoli
protein
express
presenc
glycerol
ethanol
solubl
fraction
contain
adsorb
onto
talon
affin
resin
load
ecopak
column
refold
column
use
method
describ
puriti
protein
assess
sdspage
gel
invitrogen
stain
gelcod
blue
pierc
hplc
analysi
zobax
size
exclus
column
synthet
phage
peptid
mimic
actsyneplc
gggsak
acgddwphecggg
ak
made
standard
carbonyl
chemistri
purifi
hplc
center
biolog
evalu
research
facil
biotechnolog
resourc
us
food
drug
administr
rockvil
md
peptid
confirm
expect
molecular
weight
matrixassist
laser
desorpt
ionizationtimeofflight
mass
spectroscopi
reduc
peptid
gener
previous
describ
briefli
peptid
dissolv
phosphat
buffer
incub
fold
molar
excess
tri
phosphin
tcep
nethylmaleimid
nem
room
temperatur
h
peptid
solut
store
use
elisa
polystyren
plate
corn
coat
protein
per
well
pb
overnight
unbound
remov
salin
contain
tween
pbst
nonspecif
protein
bind
block
nonfat
dri
milk
pbst
serial
dilut
block
buffer
ad
well
incub
h
well
wash
time
pbst
addit
horseradish
peroxidas
hrp
conjug
antimous
secondari
antibodi
roch
diagnost
dilut
block
buffer
h
incub
plate
wash
time
prior
applic
solubl
hrp
substrat
bm
blue
roch
diagnost
min
reaction
stop
ad
sulfur
acid
absorb
nm
determin
use
plate
reader
molecular
devic
detect
antibodi
bind
biotinyl
peptid
peptid
dilut
phosphat
buffer
ad
well
streptavidinco
plate
thermo
scientif
plate
incub
overnight
bound
antibodi
detect
describ
prepar
antibodyconjug
bead
antibodi
dilut
incub
protein
dynal
magnet
bead
invitrogen
accord
manufactur
instruct
overnight
treat
excess
crosslink
agent
room
temperatur
minut
crosslink
quench
incub
tri
buffer
unbound
antibodi
remov
incub
glycin
buffer
ph
follow
three
time
wash
pbst
buffer
protein
incub
antibodyconjug
bead
hour
room
temperatur
consist
rotat
extens
wash
pbst
bound
protein
elut
use
glycin
ph
elut
protein
analyz
sdspage
detect
stain
gelcod
blue
pierc
confluent
monolay
vero
cell
sixwel
cell
cultur
plate
corn
infect
ihdj
strain
vacv
pfu
per
well
ml
cdmem
one
well
left
uninfect
sham
control
incub
h
media
remov
cell
wash
twice
ml
pb
virusonli
well
receiv
cdmem
viru
mab
well
receiv
ml
cdmem
contain
test
well
receiv
ml
cdmem
contain
combin
concentr
protein
rang
time
molar
excess
monoclon
antibodi
experi
util
purifi
phage
instead
protein
plate
place
co
incub
maintain
hour
comet
visual
stain
monolay
crystal
violet
ethanol
neutral
buffer
formalin
prior
imag
data
obtain
niaid
viru
pathogen
databas
analysi
resourc
vipr
onlin
web
site
http
wwwviprbrcorg
wwwviprbrcorg
viral
bioinformat
resourc
center
vbrc
wwwvbrcorg
align
visual
use
multipl
sequenc
align
tool
avail
websit
statist
analysi
perform
use
prism
graphpad
softwar
experi
perform
duplic
unless
otherwis
note
